On Oct 28, major Wall Street analysts update their ratings for $NOV Inc (NOV.US)$, with price targets ranging from $21 to $25.
Morgan Stanley analyst Daniel Kutz maintains with a buy rating, and adjusts the target price from $23 to $21.
Evercore analyst James West maintains with a buy rating, and adjusts the target price from $27 to $25.
TD Cowen analyst Marc Bianchi maintains with a buy rating, and adjusts the target price from $28 to $22.
Stifel analyst Stephen Gengaro maintains with a buy rating, and adjusts the target price from $25 to $24.
RBC Capital analyst Keith Mackey maintains with a hold rating, and maintains the target price at $21.
Furthermore, according to the comprehensive report, the opinions of $NOV Inc (NOV.US)$'s main analysts recently are as follows:
The expectation is that the ongoing cycle will continue to benefit NOV Inc., with the company's emphasis on enhancing its supply chain and profitability profile predicted to increase cash flows, leading to a more rapid distribution of cash to shareholders.
NOV Inc.'s Q3 adjusted EBITDA surpassed expectations, and robust free cash flow is anticipated to back the company's substantial capital return plan. This plan is marked by a significant dividend increase, an extensive share repurchase program, and the addition of a supplementary dividend, which collectively aim to distribute an annual total equating to 50% of the company's free cash flow to its shareholders.
The firm expressed that NOV Inc.'s fourth-quarter guidance was more disappointing than anticipated due to a product mix that is impacting margins negatively. Furthermore, the outlook for a subdued first half of the year was suggested by indications that offshore drilling clients might reduce expenditures in light of impending contract intervals.
Here are the latest investment ratings and price targets for $NOV Inc (NOV.US)$ from 7 analysts:
Note:
TipRanks, an independent third party, provides analysis data from financial analysts and calculates the Average Returns and Success Rates of the analysts' recommendations. The information presented is not an investment recommendation and is intended for informational purposes only.
Success rate is the number of the analyst's successful ratings, divided by his/her total number of ratings over the past year. A successful rating is one based on if TipRanks' virtual portfolio earned a positive return from the stock. Total average return is the average rate of return that the TipRanks' virtual portfolio has earned over the past year. These portfolios are established based on the analyst's preliminary rating and are adjusted according to the changes in the rating.
TipRanks provides a ranking of each analyst up to 5 stars, which is representative of all recommendations from the analyst. An analyst's past performance is evaluated on a scale of 1 to 5 stars, with more stars indicating better performance. The star level is determined by his/her total success rate and average return.
美東時間10月28日，多家華爾街大行更新了$華高 (NOV.US)$的評級，目標價介於21美元至25美元。
摩根士丹利分析師Daniel Kutz維持買入評級，並將目標價從23美元下調至21美元。
Evercore分析師James West維持買入評級，並將目標價從27美元下調至25美元。
TD Cowen分析師Marc Bianchi維持買入評級，並將目標價從28美元下調至22美元。
斯迪富分析師Stephen Gengaro維持買入評級，並將目標價從25美元下調至24美元。
加皇資本市場分析師Keith Mackey維持持有評級，維持目標價21美元。
此外，綜合報道，$華高 (NOV.US)$近期主要分析師觀點如下：
預期是，持續的週期將繼續使華高受益，公司強調提升供應鏈和盈利能力的舉措預計將增加現金流，進而更快地向股東分配現金。
華高的第三季度調整後的EBITDA超出預期，預計強勁的自由現金流將支持公司的大規模資本回報計劃。這一計劃以顯著的股息增長、大規模的股份回購計劃以及額外的分紅爲特點，旨在將公司的自由現金流的50%年度總額分配給股東。
公司表示，由於產品組合對利潤率產生負面影響，預計華高第四季度的業績指引將比預期更令人失望。此外，鑑於海上鑽井客戶可能會在即將到來的合同間隔中減少支出，跡象表明，下半年可能會黯淡無光。
以下爲今日7位分析師對$華高 (NOV.US)$的最新投資評級及目標價：
提示:
TipRanks為獨立第三方，提供金融分析師的分析數據，並計算分析師推薦的平均回報率和勝率。提供的信息並非投資建議，僅供参考。本文不對評級數據和報告的完整性與準確性做出認可、聲明或保證。
TipRanks提供每位分析師的星級，分析師星級代表分析師所有推薦的過往表現，通過分析師的總勝率和平均回報率综合計算得出，星星越多，則該分析師過往表現越優異，最高爲5颗星。
分析師總勝率為近一年分析師的評級成功次數占總評級次數的比率。評级的成功與否，取決於TipRanks的虚擬投資組合是否從該股票中產生正回報。
總平均回報率為基於分析師的初始評級創建虚擬投資組合，並根據評級變化對組合進行調整，在近一年中該投資組合所獲得的回報率。
